Welcome to our dedicated page for Pjt Partners SEC filings (Ticker: PJT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to track how volatile advisory fees flow through PJT Partners’ statements? Each quarter, the firm’s revenue swings with deal closings, partner compensation, and restructuring mandates—all buried in dense disclosures. Stock Titan pulls those numbers forward, turning hundreds of pages into concise insights.
Our AI engine reads every filing the moment it hits EDGAR, from a PJT Partners quarterly earnings report 10-Q filing to late-night 8-K material events. Need PJT Partners insider trading Form 4 transactions? We stream them in real time and flag unusual patterns so you never miss a partner’s stock move. Curious about capital raised by Park Hill? The platform links footnote details directly to charts, providing PJT Partners earnings report filing analysis in seconds.
Here’s what you can do:
- Scan PJT Partners annual report 10-K simplified summaries to see backlog trends and segment margins.
- Receive PJT Partners Form 4 insider transactions real-time alerts before the market digests them.
- Dive into a PJT Partners proxy statement executive compensation breakdown without wading through tables.
- Click once to get PJT Partners 8-K material events explained in plain English.
- Ask natural questions like “PJT Partners SEC filings explained simply?” and our chat-style assistant delivers context.
The result: understanding PJT Partners SEC documents with AI becomes routine. Whether you monitor PJT Partners executive stock transactions Form 4 or compare quarter-over-quarter fee shifts, Stock Titan’s expert analysis and real-time updates help you act quickly and confidently.
Ryan Thomas M, a director of PJT Partners Inc. (PJT), reported a Form 4 filing showing a transaction on 09/17/2025. The filing records the acquisition of 17 restricted stock units (RSUs) that include dividend equivalent rights, each RSU representing a contingent right to one share of Class A common stock. The RSUs were reported at a price of $0 and vest according to the underlying awards. After the transaction the reporting person beneficially owns 12,831 shares of Class A common stock in a direct form. The form was signed by an attorney-in-fact on 09/19/2025.
PJT Partners Inc. director Peter L.S. Currie acquired 2 restricted stock units on 09/17/2025 that vest into Class A common stock. Each RSU converts into one share, and the report states these RSUs include dividend equivalent rights that vest with the underlying awards. After the reported grant Currie beneficially owns 1,737 shares of Class A common stock on a direct basis. The Form 4 was signed by an attorney-in-fact on 09/19/2025.
PJT Partners director James Costos received 14 restricted stock units (RSUs) on 09/17/2025, each convertible into one share of Class A common stock. The filing shows these RSUs include dividend equivalent rights that vest concurrently with the underlying awards. After the reported grant, Mr. Costos directly beneficially owns 10,386 shares of Class A common stock. The RSUs were reported as acquired (A) at a $0 price and reflect contingent rights to receive shares subject to vesting terms.
Emily K. Rafferty, a director of PJT Partners Inc. (PJT), was granted 9 restricted stock units on 09/17/2025. Each unit converts to one share of Class A common stock and includes dividend-equivalent rights that vest with the underlying awards. The award was granted at no cash price and increases Ms. Rafferty's direct beneficial ownership to 6,674 shares. The filing was signed by an attorney-in-fact on 09/19/2025.
Skaugen Grace Reksten, a director of PJT Partners Inc., reported a sale of Class A common stock on 08/07/2025. The Form 4 shows a transaction code "S" and a price of $176.89 per share, lists 500 shares disposed and reports 1,504 shares beneficially owned following the transaction, held directly. The filing is signed on 08/08/2025 and lists the reporting address as 280 Park Avenue, New York, NY 10017.